The KMT2C gene helps control when many other genes turn on and off, especially during early brain and body development. This gene plays an important role in guiding growth, learning, and development in a coordinated way. If you carry a harmful variant that disrupts this gene, it can lead to a developmental condition that may include delayed speech or motor skills, learning difficulties, behavior differences, and sometimes short stature. KMT2C is also studied in cancer because acquired variants in this gene are found in some tumors.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the code for producing proteins, which are the parts of cells that do much of the work. Other genes mainly direct when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
KMT2CGene function
What if the gene works
The KMT2C gene helps your cells control which other genes are switched on or off. This supports normal growth, development, and repair across many tissues.
Risk
What if the gene does not work
Variants in the KMT2C gene can cause developmental delay, learning difficulties, and sometimes autism. Milder or more severe variants may change when features appear and how strongly they can affect someone, and KMT2C changes also occur in some cancers.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the KMT2C gene, no treatment or management approach specific to the KMT2C gene is currently established. In cancer research, changes in the KMT2C gene are being studied as biomarkers that may help predict response to some therapies, but this is not yet routine care.
Conditions associated with KMT2C
Gene function
What if the gene works
Your cells use the KMT2C gene to help manage which instructions are read and when. It does this by placing small chemical marks on DNA packaging proteins, which makes certain stretches of DNA easier for the cell to use. This helps explain what the KMT2C gene does in the body during growth, repair, and everyday cell activity.
The KMT2C gene helps cells turn on the right genes at the right time. This supports everyday tasks such as growth, renewal, and normal cell communication.
Inside your cells, KMT2C adds small marks to histones (proteins that package DNA). These marks help organize DNA so important instructions are easier to access when needed.
KMT2C helps special DNA control regions called enhancers do their job. Enhancers act like dimmer switches, helping cells fine tune how strongly nearby genes are used.
Many cells rely on KMT2C to keep their role clear, such as whether they act like skin, blood, or nerve cells. This helps tissues keep their normal structure and routine function over time.
What is a variant?
A genetic variant is a slight change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, including appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KMT2C gene can change the shape, stability, or activity of its protein, which places chemical tags on proteins that package DNA and help control when other genes switch on. More disruptive variants may greatly reduce or stop this process, while milder variants may leave some activity. This range helps explain how KMT2C gene variants affect cells and, in some people, why related developmental features can vary in timing and severity.
How variants are linked to conditions
Pathogenic variants in the KMT2C gene cause a neurodevelopmental condition often called Kleefstra syndrome 2. Many people with KMT2C gene variants and developmental delay also have speech delay, intellectual disability, and sometimes autism or attention difficulties. Some may also have lower muscle tone. The features can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the KMT2C gene. For many living with a KMT2C gene change, the main driver of risk is the variant itself rather than clear lifestyle or environmental factors, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of KMT2C variants
Most KMT2C-related inherited conditions follow an autosomal dominant pattern, which means a child can inherit a disease-causing variant in the KMT2C gene from one affected parent. In families with this pattern, each pregnancy carries a 50% chance of passing the variant on. Some KMT2C cases happen because of a new, de novo variant, so the change is not inherited from either parent. In practical terms, KMT2C gene inheritance usually involves one altered copy being enough to cause the condition.
What does my KMT2C result mean for my family?
A harmful change in the KMT2C gene is usually linked to a condition that follows a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, the change happened new in the affected person and was not inherited from either parent. Even so, family members may want to learn whether the same result is present in them.
Genetic information
Genetic testing
How you find out about variants
A blood or saliva test for KMT2C variants lets a lab read your DNA and check this gene. Testing may use a gene panel, exome sequencing, or genome sequencing. Results may show a pathogenic variant, a benign finding, or a variant of uncertain significance.
When should I consider getting a genetic test?
People may consider KMT2C testing when there is unexplained developmental delay, speech delay, intellectual disability, autism features, or low muscle tone, especially if similar findings run in the family. Testing can help show whether these features are part of a genetic developmental condition.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. To learn more about this topic, you can explore the LearnHub.
Drugs influenced by the KMT2C gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so questions about side effects, new symptoms, or changes to treatment are best discussed with your doctor. In cancer research, KMT2C changes found in tumors are being studied for possible links to how some treatments work, but this is not yet part of standard prescribing.